| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9153213 | American Heart Journal | 2005 | 9 Pages |
Abstract
Patients with heart failure and diabetes have a much higher risk of hospitalization than patients without diabetes. Regardless of diabetic status, a highly significant reduction in hospitalizations for heart failure was observed with metoprolol CR/XL therapy, which was very well tolerated also by patients with diabetes. Furthermore, the pooled data showed a statistically significant survival benefit in patients with diabetes.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Prakash C. MD, Thomas D. MD, Michael MD,PhD, Jalal K. MD, Johan MD,PhD, Per MD,PhD, John MD,PhD, Jindrich MD, Jiri MD, Hilary PhD, John MD,PhD, MERIT-HF Study Group MERIT-HF Study Group,